Lawmakers Spar Over Exchange-Trading Mandate For Derivatives
October 14 2009 - 11:59AM
Dow Jones News
Democrats and Republicans sparred Wednesday over whether big
banks should be forced to trade some over-the-counter derivatives
on regulated trading platforms.
The debate came as the House Financial Services Committee geared
up to vote on a major bill that would impose sweeping new
regulations on the mostly opaque over-the-counter market.
An original draft of the bill did not try to force derivative
dealers or some companies heavily involved in speculative swaps
trading to trade their routine contracts on exchanges or electronic
platforms. Instead the draft contained provisions requiring them to
have some of their swaps processed through clearinghouses, which
guarantee trades, and reported to central repositories.
But on Wednesday, House Financial Services Chairman Barney
Frank, D-Mass., signaled he wants to go in a different direction
and proposed to insert a new provision into the bill that would
force major market players to both clear and trade routine products
on exchanges or electronic platforms unless the exchanges refuse to
list them.
Companies who do not hold significant over-the-counter
positions, however, would be exempt from the requirements.
Frank said he believes the lessons of past years have "been that
the systemic risk of not having this or a lot of this on exchanges
is a negative."
Republicans balked at the idea, however, saying such a drastic
change would prove harmful to businesses.
"We are now moving in the wrong direction," said Rep. Scott
Garrett, R-N.J.
Major exchanges including CME Group Inc (CME) and NYSE Euronext
(NYX) have said in recent months they do not favor a trading
mandate on derivatives.
The provision Frank proposed on Wednesday is similar to one
being proposed by the House Agriculture Committee. Frank indicated
that anything his committee approves will be tentative and subject
to future discussions with the House Agriculture Committee.
-By Sarah N. Lynch, Dow Jones Newswires; 202-862-6634;
sarah.lynch@dowjones.com.
(Michael R. Crittenden contributed to this article).